Skip to content

RELMADA THERAPEUTICS, INC.: 10-K filed 2013-12-16

What RELMADA THERAPEUTICS, INC. reported in its annual report filed 2013-12-16 (fiscal FY 2013): 20 published measures, 51 facts as tagged in accession 0001255294-13-001000.

This filing

Form
10-K (annual report)
Filed
2013-12-16
Fiscal period
fiscal FY 2013
Accession
0001255294-13-001000 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All RELMADA THERAPEUTICS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2013-08-3120,009USD
At 2012-08-3118,354USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2013-08-31-13,657USD
At 2012-08-3111,358USD
At 2011-08-319,910USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2012-09-01 to 2013-08-31-45,015USD365
2011-05-23 to 2013-08-31-50,890USD832
2011-09-01 to 2012-08-31-12,052USD366
2011-05-23 to 2011-08-31-90USD101

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2012-09-01 to 2013-08-31-11,859USD365
2011-05-23 to 2013-08-31-26,410USD832
2011-09-01 to 2012-08-31-7,565USD366

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2012-09-01 to 2013-08-31-1,800USD365
2011-05-23 to 2013-08-31-1,800USD832

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2012-09-01 to 2013-08-315,129USD365
2011-05-23 to 2013-08-3113,070USD832
2011-09-01 to 2012-08-317,941USD366

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2012-09-01 to 2013-08-3120,000USD365
2011-05-23 to 2013-08-3143,500USD832
2011-09-01 to 2012-08-3113,500USD366

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2012-09-01 to 2013-08-31-1,800USD365
2011-05-23 to 2013-08-31-1,800USD832

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2013-08-311,550USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2012-09-01 to 2013-08-31-45,015USD365
2011-05-23 to 2013-08-31-57,157USD832
2011-09-01 to 2012-08-31-12,052USD366

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2013-08-3118,459USD
At 2012-08-3118,354USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2013-08-3133,666USD
At 2012-08-316,996USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2013-08-3133,666USD
At 2012-08-316,996USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2012-09-01 to 2013-08-3146,108USD365
2011-05-23 to 2013-08-3160,392USD832
2011-09-01 to 2012-08-3114,194USD366

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2012-09-01 to 2013-08-311,093USD365
2011-05-23 to 2013-08-313,235USD832
2011-09-01 to 2012-08-312,142USD366

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2013-08-3115,000USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2012-09-01 to 2013-08-3145,076USD365
2011-05-23 to 2013-08-3154,256USD832
2011-09-01 to 2012-08-319,090USD366

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2012-09-01 to 2013-08-3120,000USD365
2011-05-23 to 2013-08-3143,500USD832
2011-09-01 to 2012-08-3113,500USD366

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2012-09-01 to 2013-08-313,236USD365
2011-05-23 to 2013-08-31-3,169USD832
2011-09-01 to 2012-08-31491USD366

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2012-09-01 to 2013-08-3120,403USD365
2011-05-23 to 2013-08-3133,500USD832
2011-09-01 to 2012-08-316,996USD366

Inspect the source

Entity
RELMADA THERAPEUTICS, INC. / CIK 0001553643
Captured
2026-09-19T11:18:56.464Z
SEC response SHA-256
34acb6579adb694402af1f940d83014f7841c8cf763b03e27ee64d386466bb53

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001553643.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))